Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 2
1987 1
1990 1
1991 2
1992 1
1993 4
1994 2
1995 3
1996 5
1997 8
1998 2
1999 4
2000 6
2001 9
2002 3
2003 18
2005 5
2006 5
2007 6
2008 8
2009 10
2010 3
2011 6
2012 4
2014 1
2015 1
2018 2
2019 5
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Results by year

Filters applied: . Clear all
Page 1
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma.
Advani R, Flinn I, Popplewell L, Forero A, Bartlett NL, Ghosh N, Kline J, Roschewski M, LaCasce A, Collins GP, Tran T, Lynn J, Chen JY, Volkmer JP, Agoram B, Huang J, Majeti R, Weissman IL, Takimoto CH, Chao MP, Smith SM. Advani R, et al. Among authors: takimoto ch. N Engl J Med. 2018 Nov 1;379(18):1711-1721. doi: 10.1056/NEJMoa1807315. N Engl J Med. 2018. PMID: 30380386 Free PMC article. Clinical Trial.
First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers.
Sikic BI, Lakhani N, Patnaik A, Shah SA, Chandana SR, Rasco D, Colevas AD, O'Rourke T, Narayanan S, Papadopoulos K, Fisher GA, Villalobos V, Prohaska SS, Howard M, Beeram M, Chao MP, Agoram B, Chen JY, Huang J, Axt M, Liu J, Volkmer JP, Majeti R, Weissman IL, Takimoto CH, Supan D, Wakelee HA, Aoki R, Pegram MD, Padda SK. Sikic BI, et al. Among authors: takimoto ch. J Clin Oncol. 2019 Apr 20;37(12):946-953. doi: 10.1200/JCO.18.02018. Epub 2019 Feb 27. J Clin Oncol. 2019. PMID: 30811285 Free PMC article. Clinical Trial.
Antimetabolites.
Chu E, Johnston PG, Takimoto CH, Politi PM, Grem JL, Chabner BA, Allegra CJ. Chu E, et al. Among authors: takimoto ch. Cancer Chemother Biol Response Modif. 1993;14:1-25. Cancer Chemother Biol Response Modif. 1993. PMID: 8312100 Review. No abstract available.
Antimetabolites.
Chu E, Johnston PG, Grem JL, Takimoto CH, Van Groeningen C, Chabner BA, Allegra CJ. Chu E, et al. Among authors: takimoto ch. Cancer Chemother Biol Response Modif. 1994;15:1-31. Cancer Chemother Biol Response Modif. 1994. PMID: 7779582 Review. No abstract available.
Antimetabolites.
Grem JL, Takimoto CH, Multani P, Chu E, Ryan D, Chabner BA, Allegra CJ, Johnston PG. Grem JL, et al. Among authors: takimoto ch. Cancer Chemother Biol Response Modif. 1999;18:1-38. Cancer Chemother Biol Response Modif. 1999. PMID: 10800475 Review. No abstract available.
Clinical applications of the camptothecins.
Takimoto CH, Wright J, Arbuck SG. Takimoto CH, et al. Biochim Biophys Acta. 1998 Oct 1;1400(1-3):107-19. doi: 10.1016/s0167-4781(98)00130-4. Biochim Biophys Acta. 1998. PMID: 9748525 Review.
New antifolates in clinical development.
Takimoto CH, Allegra CJ. Takimoto CH, et al. Oncology (Williston Park). 1995 Jul;9(7):649-56, 659 DISC 660, 662, 665. Oncology (Williston Park). 1995. PMID: 8924375 Free article. Review.
Improving attribution of adverse events in oncology clinical trials.
George GC, Barata PC, Campbell A, Chen A, Cortes JE, Hyman DM, Jones L, Karagiannis T, Klaar S, Le-Rademacher JG, LoRusso P, Mandrekar SJ, Merino DM, Minasian LM, Mitchell SA, Montez S, O'Connor DJ, Pettit S, Silk E, Sloan JA, Stewart M, Takimoto CH, Wong GY, Yap TA, Cleeland CS, Hong DS. George GC, et al. Among authors: takimoto ch. Cancer Treat Rev. 2019 Jun;76:33-40. doi: 10.1016/j.ctrv.2019.04.004. Epub 2019 Apr 25. Cancer Treat Rev. 2019. PMID: 31108240 Review.
Heat shock proteins: a potential anticancer target.
Sankhala KK, Mita MM, Mita AC, Takimoto CH. Sankhala KK, et al. Among authors: takimoto ch. Curr Drug Targets. 2011 Dec;12(14):2001-8. doi: 10.2174/138945011798829339. Curr Drug Targets. 2011. PMID: 21777196 Review.
The clinical development of 9-aminocamptothecin.
Takimoto CH, Thomas R. Takimoto CH, et al. Ann N Y Acad Sci. 2000;922:224-36. doi: 10.1111/j.1749-6632.2000.tb07041.x. Ann N Y Acad Sci. 2000. PMID: 11193898 Review.
119 results